INTRODUCTION
Ectopic activity from the PVs (pulmonary veins) is thought to initiate or drive atrial fibrillation (AF), explaining why PVI (PV isolation) is a central component in treating AF. 1 However, it is unclear why some patients remain in sinus rhythm despite PV reconnection on repeat mapping, 2 or how AF may terminate before veins are isolated. 3 We hypothesized that PV antral sites where ablation terminates AF before PV isolation may harbor AF-sustaining mechanisms that can be identified by mapping. AF mechanisms in such cases may comprise focal or rotational drivers, 4,5 ablation of which has recently shown promising acute outcomes with distinct modes of termination in recent studies, [6] [7] [8] [9] although not all [10] [11] [12] studies. We were particularly interested in whether any mapping characteristics could explain acute termination of AF.
To test our mechanistic hypothesis, we examined patients at our institution in whom prospective ablation in the PV antra terminated AF prior to PVI, using two independent methods to map mechanisms at sites of AF termination. In parallel, we studied alternative mechanisms for AF termination prior to PVI including ablation of autonomic ganglia or ablation at sites of ectopic activity near the ligament of Marshall.
METHODS

Study design
Two hundred thirty patients ≥21 years of age underwent ablation of drug-refractory paroxysmal or persistent AF at Stanford University via basket mapping by six operators between October 10, 2014 and August 1, 2016, which yielded 80 terminations of AF. We identified 22 patients in whom targeted ablation near the PVs terminated AF prior to commencing PV isolation. Electroanatomic shells were studied by three independent reviewers to determine whether sites of termination were in the peri-PV region, defined as along or within 1-2 cm of a wide-area PV isolation lesion set. Reviewers had high agreement ( = 0.87, P < 0.01). The presence of comorbid conditions, echocardiographic parameters, and lab values were obtained from each patient's electronic medical record. This study was approved by our Institutional Committee on Human Research.
Electrophysiology (EP) study and AF mapping
Each EP study was performed after discontinuing antiarrhythmic medications for five half-lives, except for n = 2 patients on amiodarone (1 discontinued 30 days prior, and 1 case not discontinued). Catheters were advanced transvenously to right atrium and coronary sinus, and transseptally to the left atrium. A 64-pole basket catheter (FIRMap, Abbott, Menlo Park, CA, USA) was used to map both atria and was moved to multiple positions to ensure adequate coverage. 13 Electroanatomic atrial shells were created in NavX (St. Jude Medical, Sylmar, CA, USA) or Carto (Biosense Webster, Diamond-Bar, CA, USA) to relate basket electrode positions to anatomy. If AF was not present at the beginning of the procedure, it was induced with rapid atrial pacing.
Ablation in all cases in this study was targeted using mapping method 1 (Rhythmview TM , Abbott), which uses activation and phase. 4, 6, 14 Briefly, unipolar AF signals (0.05-500 Hz) were recorded using basket catheters, deactivating the localization signal of the electroanatomic mapping system to minimize electronic noise.
Electrograms were analyzed using algorithms to filter far-field using monophasic potential data to estimate repolarization 15 and conduction 16, 17 and create activation maps (grayscale).
AF activation and propagation maps were analyzed to guide ablation, assisted by phase information, in which a phase singularity (red regions) radiating spiral waves that drives surrounding disorganized activity suggested a rotational driver. Focal impulses were defined by centrifugal activation from an origin driving surrounding activity. Rotational and focal sites were considered AF drivers and used to guide ablation if they lay within regions <2-3 cm 2 (<1 electrode) over > 1 minute of recordings.
Ablation
Ablation commenced at organized sites identified prospectively, via radiofrequency energy delivered by an irrigated catheter at [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] watts. Successive lesions were each applied for 15-30 seconds to cover a total area of ∼1-2 cm 2 of organized zones identified by mapping method 1. After this step, wide-area circumferential ablation (WACA) was performed with verification of PV entrance block.
Second AF mapping method
Validation of AF mapping using a second independent method was blinded to results of activation/phase mapping and sites of termination.
Unipolar AF electrograms were exported from the precise segments used by method 1 for analysis by an independent method 2. Our implementation of method 2 is described 13 and follows the steps of Kuklik et al. Briefly, the QRS complex is removed on each channel by computing an average QRS complex and subtracting it from electrograms. 18 to filter far-field timing data using action potential duration or conduction restitution, unlike the clinical method. Third, method 2 reconstructs AF signals using sinusoids, unlike the clinical system. We selected method 2 because it did not create false rotational F I G U R E 1 Termination of AF by prospectively ablating a left pulmonary vein carina rotational site prior to PVI in a 61-year-old male (panel 16 from Figure 3 ) with persistent AF. A, Electroanatomic shell showing ablation site (outlined in white, red arrow). B, Electrograms show acute AF termination during ablation and ongoing PV connection to LA. C, Still panels from Movie S1 (activation/phase mapping) show counterclockwise rotational activation at the termination site. Red-green region is Rotational Activity Profile (RAP), i.e., the automatically identified site of phase singularity clustering (rotational activity). D, Still panels from Movie S2 (method 2) also shows counterclockwise rotational activation at the same site activation in Kuklik et al., 19 which showed <1% rotational sites using 1-2 cm 2 electrode plaques in clinical studies and in sheep models of AF.
Phase maps were analyzed by three blinded operators. The location and stability of organized sites were then compared to sites identified prospectively from method 1. In two cases, digital data from the procedures was corrupted and could not be examined by mapping method 2. Rotational activity determined by both techniques was considered spatially concordant if locations differed by ≤1 electrode.
Statistical analysis
Continuous data are represented as mean ± SD (standard deviation).
Comparisons between groups were made with independent-samples 
RESULTS
Baseline characteristics
Patients were aged 60.1 ± 10.4 years, 72.7% male (Table 1) . AF was persistent in 36%. Full patient level characteristics are presented in Supplementary Table S1 . Comparing patients in whom AF terminated to AT (n = 5) versus sinus rhythm (n = 17), we found no significant difference in the incidence of hypertension (HTN), coronary artery disease (CAD), diabetes mellitus (DM), reduced ejection fraction (EF), or prior ablation procedures.
The baseline characteristics of the 22 peri-PV termination patients were also compared to the characteristics of all other patients who Table 2 . The peri-PV termination patients were slightly younger (60.0 ± 0.2 years vs. 65.0 ± 11.1 years, P = 0.05), but had similar CHADS2-VASc scores, and similar rates of other comorbidities HTN, CAD, DM2, male sex, prior ablation, and depressed EF to all activation/phase mapped patients (P = NS for all). In the PV termination cohort, there was less LA enlargement (P < 0.001) and a trend toward less persistent AF (P = 0.06) compared to all patients.
AF termination by ablation near PVs before PVI
AF terminated acutely during targeted ablation in each case, before PVI was performed and when the PVs remained electrically connected to the left atrium. Termination was to sinus rhythm in 77% of cases (Supplementary Table S2 ). 
Overall locations and validation of rotational and focal sites
Overall, sites of termination revealed rotational activation in n = 20
and focal activation in n = 2 cases. Analysis by three observers revealed a high degree of agreement on the location of drivers between methods 1 and 2, with = 0.86 (P < 0.001; three observers: GL, GM, AR). Rotational activation at the terminating source was sustained and the number of cycles observed was highly correlated between methods. Rotational circuits were interrupted by colliding wavefronts and meander, as we recently reported. 20 However, the number of cycles detected at the site of termination over 4 seconds was similar between methods: 13.4 ± 4.2 versus 12.4 ± 5.3 (method 1 vs. 2, R 2 = 0.66, P < 0.001). Thus, the driver was present for a greater percentage of the 4-second time segment when visualized using method 1 versus 2, but the difference was small (64.0% vs. 59.1%, P = 0.02). The AF driver tended to migrate by ≥1 electrode more often with mapping method 2 versus method 1 (38.9% vs. 11.1%, P = 0.12). There were also more drivers visualized using method 2 versus method 1 (2.8 ± 0.8 vs. 2.2 ± 0.8, P < 0.001). Supplementary Table S2 .
Locations and ablation sequence of rotational activation in these patients
Patients in this series had 5.1 ± 2.4 AF sources identified during activation/phase mapping in multiple basket segments (epochs). Each of these identified sites was fully ablated, except when proximity to sensitive structures precluded ablation, yielding 4.9 ± 2.2 total ablated sites.
Peri-PV locations comprise 33.1% of these sources. Other left atrial locations comprised 33.9%, and right atrial locations comprised 33.0%.
In n = 2 patients, the site of termination was the first to be addressed.
Overall, the termination site was the 1.8 ± 1.1th to be ablated out of 3.4 ± 1.8 in the left atrium, and the 3.2 ± 1.4th out of 4.9 ± 2.2 overall.
Alternative mechanisms for AF termination at peri-PV sites
Touchup of prior PVI was an alternative mechanism for AF termination. However, ablation at peri-PV organized sites did not isolate the PVs in any patient. Of n = 10 patients who presented with recurrent AF after prior PVI, all had reconnection of ≥1 PV and required additional "touch-up" to isolate the veins.
We observed similar mapping patterns, i.e., drivers and signal characteristics at the site of termination using both mapping methods in patients with and without prior ablation (driver stability in prior vs. no prior PVI by method 1: P = 0.13; method 2: P = 0.31).
We considered whether AF termination sites colocalized with GPs (Figure 3 , panels 5, 6, 8, 9, 10, 11, 19) . None of these sites showed focal activation-rotation was seen by both mapping methods. Epicardial ablation was not required to ablate or terminate these sites.
Finally, we considered whether AF terminations might be random.
Prior to termination, 5 out of 8 patients with persistent AF had continuous AF for 158 ± 52 minutes. Six out of 14 patients with paroxysmal AF had continuous AF for 148 ± 62 minutes until ablation at the site of termination. AF terminated within 1.8 ± 3.3 minutes of prospective ablation at sites demonstrating rotational or focal activation, before any further ablation including PVI was attempted.
Patients in this series were enrolled under different study protocols, and the long-term success of each is being collected. There were no deaths, no cardiac tamponade, no phrenic nerve palsy, no groin complications requiring surgical repair, and no stroke/transient ischemic attack.
DISCUSSION
We studied and mapped mechanisms for termination of persistent or paroxysmal AF by ablation near the PVs but prior to PV isolation.
Two independent mapping methods revealed sustained, organized, and predominantly rotational activation during AF at sites of termination.
As described in the preceding section, other potential mechanisms including touchup of previous ablation, GP colocalization, and random termination were not supported. To the best of our knowledge, this is the first study in which two independent AF mapping approaches were used to map AF, using the presence and site of AF termination to interpret both.
If rotational or focal activation near the PVs is confirmed in wider populations, identification of such sites a priori may help to tailor the location of PVI lesion sets to improve outcomes.
Localized sources of AF
These data add to evidence that human AF is maintained by localized sources, although the debate continues. Optical mapping of human atria show stable AF drivers on the endocardium that may colocalize with clinically identified AF sources. 21 Some clinical studies support rotational and focal sources 4, 5 with promising ablation results, [6] [7] [8] although other studies disagree. It is unclear if conflicting results reflect patient selection, mapping methodology for AF, or intercenter variations with any approach to AF ablation. 22 It also remains controversial how ablation at a rotational source may terminate AF. For instance, it is unknown if such sites reflect microreentry around scars, functional obstacles including conduction block or slowing, or other undescribed effects. Such mechanistic studies are of great importance, and may be clarified by human studies such as this where mapping systems are compared in patients with AF termination by ablation.
One unexplained issue in the driver literature to date is why ablation at some rotational drivers is associated with termination, while in others it is not. One possibility is that focal or rotational sites where ablation does not acutely terminate AF act as primary drivers at other times. 20 Another possibility is that nonterminating sites may intrinsically differ; for instance, they may be slower or be associated with cofactors such as fibrosis, which may prevent acute termination even if eliminated. Another possibility is that ablation is incomplete at sites where AF does not acutely terminate, supported by our study of recurrent AF demonstrating at least one "conserved" AF driver from prior mapping in each case. 23 Finally, it is also possible that some of these sites are false positive detections, although they were confirmed by a second mapping system.
Utility of two separate mapping techniques
The two mapping methods compared in this study revealed similar results despite their different approaches. Method 1 (activation/phase) creates AF activation maps via repolarization and conduction data to filter far-field signals, with phase as a secondary analysis. 18 Conversely, method 2 19 avoids proprietary algorithms and is phasebased yet does not appear to create false rotations in prior studies.
Both methods revealed similar spatiotemporal dynamics in AF, which may speak to the robustness of our findings. AF maps by both methods resemble optical maps of human AF, i.e., stable endocardial rotations interrupted by competing waves. 24 In preliminary studies, method 1 correlates with human optical maps 21 of AF.
It is not clear why other AF mapping studies produce different results. Known epicardial-endocardial differences in AF from optical imaging of human atria 21 may explain less stable activity on body surface mapping 5 or surgical 25 epicardial maps. Recent work shows that traditional surgical mapping by marking electrograms may encounter difficulties in the face of complex electrograms, 26 and that computational-guidance may assist activation marking of AF in such cases. 27 Other differences may reflect patient populations, differences between animal models (e.g., sheep) and human AF, or algorithmic implementation.
Further studies are needed to compare AF mapping methodologies in the same patients with an endpoint such as AF termination by ablation, as in this study. For this reason, we have made basket data and software available for download at http://narayanlab.stanford.edu (downloads tab).
Alternative mechanisms
There are other potentially localized mechanisms that cannot be definitively excluded but are not supported by our data: the majority of AF source locations did not colocalize near GPs, and no case exhibited vagal slowing during ablation that terminated AF.
Inspection of AF termination sites shows that seven sites were near the ligament of Marshall, although localized rotational sources rather than ectopy were observed. In the remaining 15 cases, termination sites were remote from the ligament of Marshall. We did not prospec- It is quite possible that the effects of AF driver ablation are additive.
In all cases, limited ablation terminated AF prior to commencing PVI.
In N = 2 patients with persistent AF, ablation at the first site near the PVs terminated AF prior to PVI. In remaining patients, ablation of earlier sites did not terminate AF, the targeted site was the second site in the left atrium and the third site ablated overall. These points and the small total of area of ablated LA and RA tissue (<5-10%) prior to PVI argues in favor of a localized mechanism of ablation, rather than by limiting critical mass for multiwavelet reentry. To further establish mechanisms, animal or clinical studies could be performed in which ablation is delivered selectively to drivers presumed to be primary, e.g., those
with high dominant frequency surrounded by gradients of stepdown, 31 versus ablation of all presumed driver sites. Another approach would be to transiently stun tissue via cryocooling to assess the impact of interrupting each driver in turn to identify "primary" from "secondary" drivers.
Terminations could in theory be related to isolation of PVs in patients with prior PVI. However, PV isolation was not seen at the point of termination, and this would not explain the 12 of 22 of patients without any prior LA ablation in whom AF terminated prior to beginning PVI. In patients with previous unsuccessful PVI, PV reconnection required subsequent touch-up lesions after AF termination in each case.
Finally, it is unclear how many AF terminations would have occurred by chance. Over one-third of patients had persistent AF and over 40% of the paroxysmal AF patients sustained AF continuously during the procedure for an average of 2.5 hours until the organized AF area was ablated, making chance termination less likely. After ablation at PV drivers, cases of paroxysmal AF no longer self-initiated spontaneously and were no longer inducible. Given that paroxysmal AF will typically need induction, we feel that these data have value even in patients with paroxysmal AF.
Clinical relevance
PVI may prevent AF recurrence in some patients by eliminating AF drivers near the PV antra. Such drivers would typically go unnoticed and may be missed by PVI lesion set that is slightly too wide or too lateral unless AF is mapped. We have observed that such AF drivers/sources may even arise just beyond or at the edge of wide lesion sets from the second generation cryoballoon. On the other hand, lesions that pass through such mechanisms may explain AF-freedom despite PV reconnection or incomplete isolation, or acute AF termination before PVI (as in this study). A prior study in a different cohort of patients showed that PVI may be unsuccessful if sites of rotational and focal activation were left unablated. 3 AF termination is a debated long-term endpoint. 32 However, we used AF termination as a clear way to judge acute efficacy of AF ablation. We included AF termination to atrial tachycardia (AT) as well as to sinus rhythm, since both represent termination of the fibrillatory process. Indeed, both rhythms are included in the vast majority of studies of AF termination. Termination of AF to sinus rhythm was more common in this series (75% to sinus) than in prior studies 33 (15% sinus) prior to PVI, albeit in different populations.
LIMITATIONS
This study has several limitations. This is a study of procedures performed by different operators. We are unable to draw conclusions about the frequency of AF termination due to PV rotational sources in general practice without consistent mapping in all patients, and without a protocol in which targeted ablation is completed prior to PVI.
This study examined only "true positive" cases-in whom ablation terminated AF-and does not comment on potential driver sites where ablation did not terminate AF.
Patients with prior ablation were included by design to assess whether sources differed between groups. Including patients with prior ablation may introduce a limitation in terms of patient heterogeneity, but is also a strength of this study. We observed similar mapping patterns, i.e., drivers and signal characteristics at the site of termination in both groups, using both mapping methods. Moreover, optical mapping studies of human atria 24, 34, 35 suggest that AF drivers may relate to scar/fibrosis which may be present whether in unablated or previously ablated patients.
We did not perform concurrent epicardial mapping. Clinical data were obtained from case records rather than from a core lab. Stochastic termination of AF cannot be excluded, but is uncommon in persistent AF, and unlikely even in patients with paroxysmal AF due to their long duration in AF prior to acute termination.
The use of AF induction is a limitation, although will be needed to study paroxysmal AF in most patients. Nevertheless, termination of persistent AF by limited ablation prior to PVI is uncommon even in patients who present in sinus rhythm, yet was seen in all patients in this study. 
CONCLUSIONS
